Financhill
Back

Akoya Biosciences Quote, Financials, Valuation and Earnings

Akoya Biosciences Price Quote

$4.83
+0.04 (+2.33%)
(Updated: December 5, 2023 at 2:59 AM ET)

Akoya Biosciences Key Stats

Sell
41
Akoya Biosciences (AKYA) is a Sell

Day range:
$4.46 - $5.17
52-week range:
$3.04 - $13.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.18
P/B ratio:
3.79%

Volume:
341.5K
Avg. volume:
109.9K
1-year change:
-62.78%
Market cap:
$235.1M
Revenue:
$74.9M
EPS:
$-1.76

How Much Does Akoya Biosciences Make?

Is Akoya Biosciences Growing As A Company?

  • What Is Akoya Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Akoya Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Akoya Biosciences Stock Price Performance

What Is Akoya Biosciences 52-Week High & Low?

Akoya Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akoya Biosciences?

  • How Much Debt Does Akoya Biosciences Have?
    Total long term debt quarterly is $63.8M
  • How Much Cash Does Akoya Biosciences Have?
    Cash and short term investments quarterly total is $78.6M
  • What Is Akoya Biosciences’s Book Value Per Share?
    Book value per share is 1.26

Is Akoya Biosciences Cash Flow Positive?

  • What Is AKYA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$55.3M
  • What Is Akoya Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $56M
  • What Is Akoya Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $26.1M

Akoya Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    AKYA return on invested capital is -57.9%
  • What Is Akoya Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -40.9%
  • What Is AKYA Return On Equity?
    ROE is a measure of profitability and is -115.28%

Akoya Biosciences Earnings Date & Stock Price

Akoya Biosciences Competitors

Akoya Biosciences Dividend Yield

Data Unavailable

Akoya Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.25%
Revenue: 33.75% 2.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.38
Upside from Last Price: 116.6%

Major Shareholders

  • How many AKYA shares are owned by institutional investors?
    21.2M AKYA shares are owned by institutional investors
  • How many AKYA shares are owned by insiders?
    2.9M AKYA shares are owned by insiders